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• Microscopic polyangiitis (MPA) is a systemic small-vessel
necrotizing vasculitis with a strong association with peri-nuclear
anti-neutrophilic cytoplasmic antibodies (p-ANCA) specific to
myeloperoxidase.  MPA has little or no immune deposit and is not
associated with granulomatous inflammation.1
• In most cases MPA presents with rapidly progressive
necrotizing glomerulonephritis and occasionally with pulmonary
hemorrhage.2 Over 70% of patients have constitutional
symptoms at diagnosis and disease manifestations may involve
any organ system.3 MPA may also present without renal or
pulmonary involvement.2,4
• Peripheral neuropathy has frequently been reported as a
symptom of ANCA-associated vasculitis and is commonly
present at disease onset.  It may also be an initial manifestation
of the disease state, but there is limited evidence comparing
the incidence of neuropathy with the other manifestations of
systemic vasculitides.1,4,5
• Studies have shown that a majority of those with ANCAassociated vasculitis report peripheral neuropathy at some point
in the disease process, but less than 25% report it at initial
presentation.  Among the ANCA-associated vasculitides, MPA
appears to have the lowest incidence of reported peripheral
neuropathy, sensory or motor.1,5
• A recent case report of MPA presents a patient with lower
extremity polyneuropathy preceding renal  manifestations.6
• MPA is treated in two phases:  Induction phase is acute treatment
with systemic corticosteroids and immunosuppressive agents
such as cyclophosphamide or rituximab.  Maintenance phase
begins 1-2 months after resolution of inflammation and typically
involves azathioprine.7,8  Patients may also be treated with
plasma exchange during induction.2,8

A 58 year old woman without significant past medical history
presented with the chief complaints of weakness and loss of balance.  
She described a weakness and heaviness of her bilateral lower
extremities and felt off-balance with difficulty ambulating.  She also
described a clumsiness and inability to correctly use her left hand.
This occurred in the context of a one year history of “pins and needles”
sensation in her bilateral feet.
Physical exam revealed a stocking-glove distribution of decreased
pinprick sensation, decreased vibration sense in the bilateral toes,
ataxic gait, and a positive Romberg sign.  The patient underwent
extensive imaging revealing the following results:

Our case is a rare presentation of microscopic polyangiitis (MPA) with
concurrent diffuse alveolar hemorrhage and dialysis dependent rapidly
progressive glomerulonephritis in the setting of long-standing bilateral
stocking-glove pure sensory symmetric peripheral neuropathy.  
Previous literature has demonstrated that a majority of those with
ANCA-associated vasculitis report peripheral neuropathy at some point
in the disease process, but few had active vasculitic neuropathy at
baseline.
Patients with vasculitic nephropathy at baseline have a higher median
number of organ systems involved when compared with those without
neuropathy, and also reported higher Birmingham Vasculitis Activity
Scores; a clinical checklist of items organized by organ systems used
to determine disease activity.
The European Vasculitis Study Group trials showed that a pure sensory
neuropathy, which our patient developed early in her disease course,
was not reported in any patients with MPA.  However, our patient did
not undergo electrophysiologic confirmation of her neuropathy.
Studies demonstrate that non-specific symptoms may be present for
months to years prior to diagnosis of MPA.  This case demonstrates
the difficulty of recognizing MPA when only a single organ system
is involved and that ANCA-associated vasculitis should be included
on the differential diagnosis of peripheral neuropathy with unclear
etiology.  It also exemplifies the need for further research on peripheral
neuropathy in systemic vasculitides, specifically in MPA where these
early presenting signs have previously shown to be less prevalent.

• C
 T Head: no acute abnormality  
• M
 RA Head/Neck: 50% stenosis of proximal right ICA, 75% stenosis
of left ICA, both felt to be artifactual
• M
 RI Brain: scattered foci of non-specific supratentorial white matter
signal abnormality, no acute abnormality
• C
 hest XR: interstitial prominence laterally at both lung bases most
likely represents chronic interstitial disease
• 2
 D ECHO: aneurysmal interatrial septum without evidence of shunt,
EF 60%
• C
 T Chest: interstitial lung disease, mild mediastinal and hilar
adenopathy, mild honeycombing at bilateral bases
• C
 T Abd/Pelvis: 6cm cystic right pelvis mass, likely ovarian cyst

Laboratory studies revealed an elevated erythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP), positive rheumatoid factor
(RF), and elevated serum creatinine.  Patient was ultimately discharged
home with a diagnosis of peripheral neuropathy, secondary to thiamine
deficiency.
Three months after discharge the patient presented with the acute
onset of substernal chest pain exacerbated by inspiration and
associated with shortness of breath.
Initial laboratory examination revealed marked acute oligoanuric
First Admission
Second Admission
renal failure, proteinuria, anemia, and new diffuse bilateral perihilar
11.1 / 33
Hemoglobin / Hematocrit
6.2 / 18.1
infiltrates on chest x-ray and CT.  Bronchoscopy revealed acute
1.47
Serum Creatinine
5.89
alveolar hemorrhage.  Further laboratory studies showed elevated anti100
ESR
125
2.2
CRP
10.3
myeloperoxidase anti-neutrophilic cytoplasmic antibodies (p-ANCA).  
780
Rheumatoid Factor
584
The patient then underwent renal biopsy which demonstrated acute
CCP Antibody
Negative
and chronic pauci-immune necrotizing, sclerosing, and crescentic
Negative
ANA Panel with Reflex
Negative
Negative
Lyme Titer
glomerulonephritis associated with focal necrotizing vasculitis;
6.3%
HgbA1c
5.9%
typical of changes seen with p-ANCA seropositivity and leading to the
ASO Titer
27 (Ref. <240)
diagnosis of microscopic polyangiitis.
Hepatitis/HIV Screen
Negative
ACE Level
29 (Ref. 9-67)
The patient was initiated on hemodialysis due to her rapidly
C-ANCA (PR3)
6.2 (ref. <20)
P-ANCA (MPO)
148 (Ref. <20)
progressive glomerulonephritis.  She was treated with pulse dose
Anti-GBM
Negative
methylprednisolone followed by stress dose prednisone, as well
Cryoglobulins
Negative
as therapeutic plasma exchange and oral cyclophosphamide.  She
Chronic inflammatory stress response
SPEP Interpretation
Polyclonal hypergammaglobulinemia
remains dialysis dependent despite two weaning attempts and is
Table 1. Selected laboratory values from two hospital admissions.   currently undergoing transplant evaluation.  Her cyclophosphamide
Hemoglobin/ Hematocrit and serum creatinine are from initial
was transitioned to azathioprine, and she remains on prednisone.
presentations.

Figure 1. Chest x-ray from
second admission showing
new diffuse bilateral perihilar
opacities.

Figure 2. CT of the chest

from second admission
demonstrating alveolar
groundglass opacities and air
bronchograms.
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Figure 3. Light microscopy
of renal biopsy demonstrating
crescentic glomerulonephritis.

Figure 4. Light microscopy
of kidney biopsy again
demonstrating compression
of the glomerulus by a cellular
crescent.
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